Meet with us at

ChemSpec Europe 2023

May 24 - May 25, 2023


Registration Closes In




ChemSpec Europe 2023

The 36th International Exhibition for Fine and Speciality Chemicals will take place from 24 - 25 May 2023, at Messe Basel, Switzerland. The exhibition features the full spectrum of fine and speciality chemicals for various applications and industries. A first-rate conference programme accompanies the event and offers plenty of additional networking opportunities to exchange industry know-how and form international relations with peers and business partners.

Stop by Curia's Booth #C110


Schedule a meeting with Curia's experts




Featured Sessions

Beyond Amide Bond Formation: T3P® as General Reagent for Reactions based on Water Removal
May 24 13:00-13:30

image description
Dr. Jörg Jung
Senior Director, Custom Synthesis

Dr. Joerg Jung is Senior Director R&D at Curia and heads the Chemical Development team in Frankfurt.  Joerg received his Ph.D. in organsssometallic chemistry from the University of Giessen (Germany) in 1996.  He has more than 20 years experience in the CS/CMO industry, serving major pharmaceutical companies worldwide.  His core expertise is organometallic chemistry, cross-coupling chemistry and heterocyclic chemistry with focus on the development of robust and economic processes for rapid scale-up from the lab to a multi-100 kg scale.



Pharma Outsourcing Panel
May 25th 11:00-12:00

image description 
Joachim Kaus 
Managing Director Germany

Joachim Kaus is Managing Director at Curia Germany GmbH and heading the Frankfurt site.  Joachim is a chemical / biotechnology engineer with experiences in development of API´s and intermediates. He has more than 30 years of experience in the pharma industry, to develop and scale up API´s and intermediates from lab scale to metric ton production. 

At Curia, every partnership is an opportunity to transform an idea to impact.

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.

To learn more visit us at curiaglobal.com

Messe Basel

Basel, Switzerland

Curia is Hiring!

Be the conduit that connects ideas to solutions. Contribute to the creation and distribution of treatments that enhance and save lives. Ensure that medicines are more accessible and help breakthroughs break through faster. The impact is real at Curia (formerly Albany Molecular Research, Inc.), and you can help us take it to even greater heights.


Scientific Expertise. Market-Leading Technology.
Best-in-Class Solutions.

AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.

Discover our Expert Solutions